front 1 Elevated waist circumference in men | back 1 >/= 40 in |
front 2 Elevated waist circumference in women | back 2 >/= 35 in |
front 3 Elevated TG level | back 3 >/= 150 mg/dL |
front 4 Reduced LDL in women | back 4 <50 mg/dL |
front 5 Reduced LDL in men | back 5 <40 mg/dL |
front 6 Elevated BP reading | back 6 >/= 130/80 mmHg |
front 7 Elevated FBG reading | back 7 >/= 100 mg/dL |
front 8 How many measures does a patient need to meet to be diagnosed with metabolic syndrome | back 8 3 of 5 |
front 9 underweight BMI | back 9 <18.5 |
front 10 normal BMI | back 10 18.5 - 24.9 |
front 11 Overweight BMI | back 11 25-29.9 |
front 12 Obese class I | back 12 30-34.9 |
front 13 Obese class II | back 13 35-39.9 |
front 14 Obese class III | back 14 >/= 40 |
front 15 Elevated waist circumference in Asian men | back 15 >/= 33.5 |
front 16 Elevated waist circumference in Asian women | back 16 >/= 29-31.5 |
front 17 what BMI is indicated for weight loss surgery? | back 17 BMI >/= 40 or BMI >/=35 and at least one or more severe obesity-related complications |
front 18 Pharmacotherapy for overweight/obesity should be used only as an adjunct to lifestyle therapy and not alone? | back 18 True |
front 19 BMI to prescribe weight loss meds? | back 19 BMI >/= 30 or BMI >/= 27 with at least one or more severe obesity-related complications |
front 20 What are the three short term agents | back 20 1. Phentermine 2. Phendimetrazine 3.Diethylpropion |
front 21 ADE of phentermine | back 21 Increased BP Insomnia palpitations arrhythmias |
front 22 4 contraindications of phentermine | back 22 1. Hyperthyroidism 2. History of CV disease 3. Abusers of cocaine/meths 4. Use during or with MAOIs |
front 23 Phentermine is a CIII? | back 23 False: CIV |
front 24 Monitoring of short acting agents: | back 24 Baseline cardiac evaluation ECG during therapy BP D/C if not weight loss in 4 weeks |
front 25 Phentermine should be abruptly d/c'd? | back 25 False: may cause extreme fatigue and depression |
front 26 ADE of Alli | back 26 soft stool, abdominal pain or colic, flatulence, fecal urgency |
front 27 What should be monitored on Alli | back 27 thyroid and liver function |
front 28 Which agent may need backup contraception? | back 28 Alli |
front 29 Brand name of phentermine-topiramate | back 29 Qsymia |
front 30 What agent must be titrated up? | back 30 Qsymia |
front 31 ADE of Qsymia | back 31 Constipation, dry mouth, paresthesia, dysgeusia, insomnia, tachycardia |
front 32 What should be monitored on Qsymia | back 32 HR, electrolytes, SCr, depression or suicidal thoughts, mood to sleep disorders |
front 33 Three CI of Qsymia | back 33 1. Glaucoma 2. Untreated hyperthyroidism 3. Pregnancy |
front 34 What agent has a REMS program for pregnancy? | back 34 Qsymia |
front 35 What is the brand name for naltrexone-bupropion? | back 35 Contrave |
front 36 ADE of naltrexone | back 36 hepatotoxicity |
front 37 ADE of bupropion | back 37 suicidal ideation, activation of mania, angle-closure glaucoma |
front 38 6 CI with Contrave | back 38 1. Seizure disorder 2. Bulimia/anorexia 3. Concurrent use of MAOIs 4. Chronic opioid use 5. Uncontrolled HTN 6. Abrupt withdrawal of chronic alcohol, BZDs, barbiturates, or anti epileptics |
front 39 Which agent has DDIs with CYP2B6 inducers and CYP2D6 substrates and should not be taken with a high fat meal? | back 39 Contrave |
front 40 Brand name of liraglutide | back 40 Saxenda |
front 41 Target dose of saxenda | back 41 3 mg SQ QD |
front 42 Target dose of wegovy | back 42 2.4 mg SQ weekly |
front 43 How often should a patient be monitored while on weight loss therapy? | back 43 Monthly for the first three months Then every 3 months thereafter |